J
Jacques J. Bergman
Researcher at University of Amsterdam
Publications - 403
Citations - 17210
Jacques J. Bergman is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Barrett's esophagus & Dysplasia. The author has an hindex of 61, co-authored 372 publications receiving 14651 citations.
Papers
More filters
Journal ArticleDOI
The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.
Prateek Sharma,John Dent,David Armstrong,Jacques J. Bergman,Liebwin Gossner,Yoshio Hoshihara,Janusz Jankowski,Ola Junghard,Lars Lundell,Guido N. J. Tytgat,Michael Vieth +10 more
TL;DR: The Prague C & M Criteria have high overall validity for the endoscopic assessment of visualized Barrett's esophagus lengths.
Journal ArticleDOI
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte,Evgeni Levin,Jarkko Salojärvi,Loek P. Smits,Annick V. Hartstra,Shanti D. Udayappan,Gerben D. A. Hermes,Kristien E. C. Bouter,Annefleur M. Koopen,Jens J. Holst,Filip K. Knop,Ellen E. Blaak,Jing Hua Zhao,Hauke Smidt,Amy C. Harms,Thomas Hankemeijer,Jacques J. Bergman,Hans A. Romijn,Frank G. Schaap,Steven W.M. Olde Damink,Mariëtte T. Ackermans,Geesje M. Dallinga-Thie,Erwin G. Zoetendal,Willem M. de Vos,Mireille J. Serlie,Erik S.G. Stroes,Albert K. Groen,Max Nieuwdorp +27 more
TL;DR: The beneficial effects of lean donor FMT on glucose metabolism are associated with changes in intestinal microbiota and plasma metabolites and can be predicted based on baseline fecal microbiota composition.
Journal ArticleDOI
Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia: A Randomized Clinical Trial
K. Nadine Phoa,Frederike G. Van Vilsteren,Bas L. Weusten,Raf Bisschops,Erik J. Schoon,Krish Ragunath,Grant Fullarton,Massimiliano di Pietro,Narayanasamy Ravi,Mike Visser,G. Johan A. Offerhaus,Cees A. Seldenrijk,Sybren L. Meijer,Fiebo J.W. ten Kate,Jan G.P. Tijssen,Jacques J. Bergman +15 more
TL;DR: Radiofrequency ablation resulted in a reduced risk of neoplastic progression over 3 years of follow-up and the data and safety monitoring board recommended early termination of the trial due to superiority of ablation for the primary outcome and the potential for patient safety issues if the trial continued.
Journal ArticleDOI
Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement
Bas L. Weusten,Raf Bisschops,Emanuel Coron,Mário Dinis-Ribeiro,Jean-Marc Dumonceau,José Miguel Esteban,Cesare Hassan,Oliver Pech,Alessandro Repici,Jacques J. Bergman,Massimiliano di Pietro +10 more
TL;DR: The Position Statement wishes to contribute to a more cost-effective approach to the care of patients with BE by reducing the number of surveillance endoscopies for patients with a low risk of malignant progression and centralizing care in expert centers for those with high progression rates.
Journal ArticleDOI
Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
Wouter L. Curvers,Fiebo J.W. ten Kate,Kausilia K. Krishnadath,Mike Visser,Brenda Elzer,Lubertus C. Baak,Clarisse J M Böhmer,R.C. Mallant-Hent,Arnout van Oijen,Anton H. Naber,Pieter Scholten,Olivier R. Busch,Harriët G T Blaauwgeers,Gerrit A. Meijer,Jacques J. Bergman +14 more
TL;DR: LGD in BE is an overdiagnosed and yet underestimated entity in general practice and patients diagnosed with LGD should undergo an expert pathology review to purify this group.